RecallRadar

FDA Drug recall D-0838-2026

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA,…

On 2026-09-09 the FDA classified a Class III recall of Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA,… by Chiesi Usa, citing failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0838-2026
ClassificationClass III
Statusongoing
Initiated2026-08-19
Published2026-09-09
Last updated2026-09-23 05:30 UTC
CompanyChiesi Usa
DistributionMO, TN

Product

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Reason

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Identifiers

ndc10122-502-01
code_infoLot#: 1221973, Exp 3/24/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-23 05:30 UTC. Current status: ongoing.

Other recalls by Chiesi Usa

All Chiesi Usa recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0838-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.